Clinical Trial Update: MAGE-A3 Protein + AS15 as Consolidation for Multiple Myeloma Patients Undergoing Autologous Stem Cell Transplantation [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating MAGE-A3 protein plus AS15 as consolidation therapy after autologous stem cell transplantation in multiple myeloma patients; study compl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• AS15 (AS15 adjuvant)
• MAGE-A3 (MAGE-A3 tumor antigen)

Snippet

Sponsor: Ludwig Institute for Cancer Research | Conditions: Multiple Myeloma | Phase 1 | Status: COMPLETED | Results posted: 2016-12-22